Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stephenson AJ et al. – ALNMD is a significant predictor of RFS and OS after adjusting for standard prognostic parameters among patients with LN–positive UCB and may be a useful parameter to include in future predictive nomograms and TNM–staging systems.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address